FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * SCHWARTZ ALICE N   2. Issuer Name and Ticker or Trading Symbol BIO RAD LABORATORIES INC [BIO, BIO.B] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE 3. Date of Earliest Transaction (Month/Day/Year) 06/10/2010 (Street) HERCULES, CA 94547 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Bio-Rad A Common Stock 02/12/2010   G V 274 D $ 0 1,404,588 (1) D   Bio-Rad A Common Stock 04/29/2010   G V 8,086 D $ 0 825,208 (1) I By GRAT Bio-Rad A Common Stock 04/29/2010   G V 8,086 D $ 0 825,208 (1) I by GRAT (spouse) Bio-Rad A Common Stock               34,311 I By Trust Bio-Rad B Common Stock 02/12/2010   G V 1,644 D $ 0 390,056 D   Bio-Rad B Common Stock 06/10/2010   M   334 (2) A $ 0 390,390 D   Bio-Rad B Common Stock               4,060,054 I By Blue Raven Partners, L.P. (3) Bio-Rad B Common Stock               41,176 I By DANSA Partners Limited (4)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
SCHWARTZ ALICE N C/O BIO-RAD LABORATORIES, INC. 1000 ALFRED NOBEL DRIVE HERCULES, CA 94547	X	X

Signatures

Alice N. Schwartz		06/14/2010
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	In addition to the reported transaction, the following non-reportable transactions are reflected in the Amount of Securities Beneficially Owned Following Reported Transactions (Column 5): (1) on July 24, 2009, the reporting person and the reporting person's spouse each transferred 825,208 shares to an independent trustee of separate GRATS for the respective benefit of the grantors for estate planning purposes and, (2) on April 29, 2010, the reporting person and the reporting person's spouse each received 90,661 Class A shares as a distribution from their separate 2008 GRATs to their direct beneficial holdings.
(2)	Shares of Class B common stock issued to spouse on the vesting of restricted stock units. Reporting person is the spouse of David Schwartz, Chairman of the Board of Bio-Rad Laboratories and beneficial owner of more than 10% of the Company's common stock.
(3)	The shares are held by a limited partnership of which the reporting person is a limited and general partner.
(4)	The shares are held by a limited partnership of which the reporting person is a general partner.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.